Literature DB >> 33865912

Subtype-Specific Analyses Reveal Infiltrative Basal Cell Carcinomas Are Highly Interactive with their Environment.

Rehan Villani1, Valentine Murigneux2, Josue Alexis3, Seen-Ling Sim1, Michael Wagels4, Nicholas Saunders1, H Peter Soyer5, Laurent Parmentier6, Sergey Nikolaev7, J Lynn Fink1, Edwige Roy1, Kiarash Khosrotehrani8.   

Abstract

Little is known regarding the molecular differences between basal cell carcinoma (BCC) subtypes, despite clearly distinct phenotypes and clinical outcomes. In particular, infiltrative BCCs have poorer clinical outcomes in terms of response to therapy and propensity for dissemination. In this project, we aimed to use exome sequencing and RNA sequencing to identify somatic mutations and molecular pathways leading to infiltrative BCCs. Using whole-exome sequencing of 36 BCC samples (eight infiltrative) combined with previously reported exome data (58 samples), we determine that infiltrative BCCs do not contain a distinct somatic variant profile and carry classical UV-induced mutational signatures. RNA sequencing on both datasets revealed key differentially expressed genes, such as POSTN and WISP1, suggesting increased integrin and Wnt signaling. Immunostaining for periostin and WISP1 clearly distinguished infiltrative BCCs, and nuclear β-catenin staining patterns further validated the resulting increase in Wnt signaling in infiltrative BCCs. Of significant interest, in BCCs with mixed morphology, infiltrative areas expressed WISP1, whereas nodular areas did not, supporting a continuum between subtypes. In conclusion, infiltrative BCCs do not differ in their genomic alteration in terms of initiating mutations. They display a specific type of interaction with the extracellular matrix environment regulating Wnt signaling.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33865912     DOI: 10.1016/j.jid.2021.02.760

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

Review 1.  Periostin: an emerging activator of multiple signaling pathways.

Authors:  Zhaoheng Wang; Jiangdong An; Daxue Zhu; Haiwei Chen; Aixin Lin; Jihe Kang; Wenzhao Liu; Xuewen Kang
Journal:  J Cell Commun Signal       Date:  2022-04-12       Impact factor: 5.782

2.  Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease.

Authors:  Kenneth G Trieu; Shih-Ying Tsai; Markus Eberl; Virginia Ju; Noah C Ford; Owen J Doane; Jamie K Peterson; Natalia A Veniaminova; Marina Grachtchouk; Paul W Harms; Fredrik J Swartling; Andrzej A Dlugosz; Sunny Y Wong
Journal:  Cell Rep       Date:  2022-05-03       Impact factor: 9.995

Review 3.  Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments.

Authors:  Eliana B Souto; Raquel da Ana; Vânia Vieira; Joana F Fangueiro; João Dias-Ferreira; Amanda Cano; Aleksandra Zielińska; Amélia M Silva; Rafał Staszewski; Jacek Karczewski
Journal:  Neoplasia       Date:  2022-05-29       Impact factor: 6.218

Review 4.  Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers.

Authors:  Taku Fujimura
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

5.  Integrated multi-omics reveals cellular and molecular interactions governing the invasive niche of basal cell carcinoma.

Authors:  Laura Yerly; Christine Pich-Bavastro; Jeremy Di Domizio; Tania Wyss; Stéphanie Tissot-Renaud; Michael Cangkrama; Michel Gilliet; Sabine Werner; François Kuonen
Journal:  Nat Commun       Date:  2022-08-20       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.